[1] Borja Ibanez, Stefan James, Stefan Agewall, Manuel J Antunes, Chiara Bucciarelli-Ducci, Héctor Bueno, Alida L P Caforio, Filippo Crea, John A Goudevenos, Sigrun Halvorsen, Gerhard Hindricks, Adnan Kastrati, Mattie J Lenzen, Eva Prescott, Marco Roffi, Marco Valgimigli, Christoph Varenhorst, Pascal Vranckx, Petr Widimský. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation: the task force for the management of acute myocardial infarction in patients presenting with STsegment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2018; 39: 11977.
[2] Stuart J Head, Milan Milojevic, Joost Daemen, Jung-Min Ahn, Eric Boersma, Evald H Christiansen, Michael J Domanski, Michael E Farkouh, Marcus Flather, Valentin Fuster, Mark A Hlatky, Niels R Holm , Whady A Hueb, Masoor Kamalesh, Young-Hak Kim, Timo Mäkikallio , Friedrich W Mohr, Grigorios Papageorgiou, Seung-Jung Park, Alfredo E Rodriguez, Joseph F Sabik 3rd, Rodney H Stables, Gregg W Stone, Patrick W Serruys, A Pieter Kappetei. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization [J]. J. Am. Coll. Cardiol, 2018, 72(4):386-398.
[3] Pieter J Vlaar, Tone Svilaas, Iwan C van der Horst, Gilles F H Diercks, Marieke L Fokkema, Bart J G L de Smet, Ad F M van den Heuvel, Rutger L Anthonio, Gillian A Jessurun, Eng-Shiong Tan, Albert J H Suurmeijer, Felix Zijlstra. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 2008; 371:1915–1920.
[4] Ph Gabriel Steg, Stefan K James, Dan Atar, Luigi P Badano, Carina Blömstrom-Lundqvist, Michael A Borger, Carlo Di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernandez-Aviles, Anthony H Gershlick, Pantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, Juhani Knuuti, Mattie J Lenzen, Kenneth W Mahaffey, Marco Valgimigli, Arnoud van 't Hof, Petr Widimsky, Doron Zahger. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33:2569–2619.
[5] Tim Kinnaird, Thomas Johnson , Richard Anderson, Sean Gallagher, Alex Sirker, Peter Ludman , Mark de Belder, Samuel Copt, Keith Oldroyd , Adrian Banning, Mamas Mamas, Nick Curzen. Intravascular imaging and 12-month mortality after unprotected left main stem PCI: An analysis From the British Cardiovascular Intervention Society Database[J]. JACC. Cardiovascular Interventions, 2020, 10;13(3):346-357.
[6] Anna V Kontsevaya, Katie Bates, Henrik Schirmer, Natalia Bobrova David Leon, Martin McKee. Management of patients with acute ST-segment elevation myocardial infarction in Russian hospitals adheres to international guidelines[J]. Open Heart, 2020, 23;7(1):e001134.
[7] Mitsuhiro Takeuchi, Manabu Ogita , Hideki Wada , Daigo Takahashi, Yui Nozaki, Ryota Nishio, Kentaro Yasuda, Norihito Takahashi , Taketo Sonoda, Shoichiro Yatsu, Jun Shitara, Shuta Tsuboi, Tomotaka Dohi, Satoru Suwa, Katsumi Miyauchi, Hiroyuki Daida. Comparison of long-term mortality between living alone patients vs. living together patients with acute coronary syndrome treated with percutaneous coronary intervention[J]. Eur Heart J Qual Care Clin Outcomes. 2020
[8] B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, E H Barnes, M Voysey, A Gray, R Collins, C Baigent. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; 380: 581–90.
[9] Sundström J, Jackson R, Neal B, for the BPLTTC. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014; 384: 591–98.
[10] Si-Hyuck Kang, Keun Ho Park, Hyo-Suk Ahn, Kyung Woo Park, Young Joon Hong, Bon-Kwon Koo, Myung Ho Jeong, Hyo-Soo Kim. Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus. EuroIntervention 2014;10(1):74-82.
[11] Somjot S Brar, John Kim, Simerjeet K Brar, Ray Zadegan, Michael Ree, In-Lu A Liu, Prakash Mansukhani, Vicken Aharonian, Ric Hyett, Albert Yuh-Jer Shen. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. J Am Coll Cardiol 2008; 51(23):2220-7.
[12] Usman Baber, Jeffrey Bander, Rucha Karajgikar, Kapil Yadav, Ali Hadi, Kleanthis Theodoropolous, Nilusha Gukathasan, Swathi Roy, Swapna Sayeneni, Stuart A Scott, Jason C Kovacic, Jennifer Yu, Samantha Sartori, Roxana Mehran, Jaime Uribarri, Juan J Badimon, Paul Muntner, Pedro Moreno, Annapoorna S Kini, Samin K Sharma. Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost 2013;110(1):118-23.
[13] Usman Baber, Roxana Mehran, Ajay J Kirtane, Paul A Gurbel , Georgios Christodoulidis , Akiko Maehara, Bernhard Witzenbichler, Giora Weisz, Michael J Rinaldi, D Christopher Metzger , Timothy D Henry , David A Cox, Peter L Duffy, Ernest L Mazzaferri Jr , Ke Xu, Helen Parise 1 , Bruce R Brodie , Thomas D Stuckey , Gregg W Stone. Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry. Circ Cardiovasc Interv 2015;8(6):e001683.
[14] Dominick J Angiolillo, Esther Bernardo, Davide Capodanno, David Vivas, Manel Sabaté, José Luis Ferreiro, Masafumi Ueno, Pilar Jimenez-Quevedo, Fernando Alfonso, Theodore A Bass, Carlos Macaya, Antonio Fernandez-Ortiz. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol 2010;55(11):1139-46.
[15] Morrow DA. Cardiovascular risk prediction in patients with stable and unstable coronary heart disease. Circulation 2010;121(24):2681-91.
[16] George D Dangas 1 , Bimmer E Claessen, Roxana Mehran, Ke Xu, Martin Fahy, Helen Parise, José P S Henriques, E Magnus Ohman, Harvey D White, Gregg W Stone. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv 2012;5(11): 1097-105.
[17] Sunil V Rao, Lisa A McCoy, John A Spertus, Ronald J Krone, Mandeep Singh, Susan Fitzgerald, Eric D Peterson. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv 2013;6(9): 897-904.
[18] Roxana Mehran, Usman Baber, Samin K Sharma, David J Cohen, Dominick J Angiolillo, Carlo Briguori, Jin Y Cha, Timothy Collier, George Dangas , Dariusz Dudek , Vladimír Džavík , Javier Escaned, Robert Gil , Paul Gurbel, Christian W Hamm, Timothy Henry, Kurt Huber, Adnan Kastrati , Upendra Kaul, Ran Kornowski, Mitchell Krucoff, Vijay Kunadian, Steven O Marx, Shamir R Mehta, David Moliterno, E Magnus Ohman, Keith Oldroyd, Gennaro Sardella, Samantha Sartori, Richard Shlofmitz, P Gabriel Steg, Giora Weisz, Bernhard Witzenbichler, Ya-Ling Han, Stuart Pocock, C Michael Gibson. Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med, 2019, 381(21): 2032-2042.
[19] Ph Gabriel Steg, Stefan K James, Dan Atar, Luigi P Badano, Carina Blömstrom-Lundqvist, Michael A Borger, Carlo Di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernandez-Aviles, Anthony H Gershlick, Pantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, Juhani Knuuti, Mattie J Lenzen, Kenneth W Mahaffey, Marco Valgimigli, Arnoud van 't Hof, Petr Widimsky, Doron Zahger. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33:2569-2619.
[20] Patrick T O'Gara, Frederick G Kushner, Deborah D Ascheim, Donald E Casey Jr, Mina K Chung, James A de Lemos, Steven M Ettinger, James C Fang, Francis M Fesmire, Barry A Franklin, Christopher B Granger, Harlan M Krumholz, Jane A Linderbaum, David A Morrow, L Kristin Newby, Joseph P Ornato, Narith Ou, Martha J Radford, Jacqueline E Tamis-Holland, Jacqueline E Tommaso, Cynthia M Tracy, Y Joseph Woo, David X Zhao. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2013; 127: 529-55.
[21] Ce Zhang, Lin Jiang, Lianjun Xu, Jian Tian, Junhao Liu, Xueyan Zhao, Xinxing Feng, Dong Wang, Yin Zhang, Kai Sun, Bo Xu, Wei Zhao, Rutai Hui, Runlin Gao, Jinqing Yuan, Lei Song. Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease[J]. European Heart Journal (41):40. 3397–3405,
[22] Chengchun Tan, Erfei Luo, Dong Wang, Gaoliang Yan, Yong Qiao, Boqian Zhu, Bo Liu, Jiantong Hou. Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI[J]. BioMed Research International, 2019, 2019(8):1-8.
[23]Doyle BJ, Rihal CS, Gastineau DA, Holmes DR Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol, 2009;53:2019–27.
[24] Sunil V Rao, Padma R Kaul, Lawrence Liao, Paul W Armstrong, E Magnus Ohman, Christopher B Granger, Robert M Califf, Robert A Harrington, Eric L Eisenstein, Daniel B Mark. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2008;155:369–74.
[25]Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv 2005;65:196–202.
[26] Ajay J Kirtane, Gregory Piazza, Sabina A Murphy, Daniela Budiu, David A Morrow, David J Cohen, Eric Peterson, Nasser Lakkis, Howard C Herrmann, Theresa M Palabrica, C Michael Gibson. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. J Am Coll Cardiol 2006; 47:2374–9.
[27] Freek W A Verheugt, Steven R Steinhubl, Martial Hamon, Harald Darius, Philippe Gabriel Steg, Marco Valgimigli, Steven P Marso, Sunil V Rao, Anthony H Gershlick, A Michael Lincoff, Roxana Mehran, Gregg W Stone. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. J Am Coll Cardiol Intv 2011;4:191–7.
[28] Sunil V Rao, Fang-Shu Ou, Tracy Y Wang, Matthew T Roe, Ralph Brindis, John S Rumsfeld, Eric D Peterson. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the national cardiovascular data registry. J Am Coll Cardiol Intv 2008;1:379–86.
[29] Emelia J Benjamin, Michael J Blaha, Stephanie E Chiuve, Mary Cushman, Sandeep R Das, Rajat Deo, Sarah D de Ferranti, James Floyd, Myriam Fornage, Cathleen Gillespie, Carmen R Isasi, Monik C Jiménez, Lori Chaffin Jordan, Suzanne E Judd, Daniel Lackland, Judith H Lichtman, Lynda Lisabeth, Simin Liu, Chris T Longenecker, Rachel H Mackey, Kunihiro Matsushita, Dariush Mozaffarian, Michael E Mussolino, Khurram Nasir, Robert W Neumar, Latha Palaniappan, Dilip K Pandey, Ravi R Thiagarajan, Mathew J Reeves, Matthew Ritchey, Carlos J Rodriguez, Gregory A Roth, Wayne D Rosamond, Comilla Sasson, Amytis Towfighi, Connie W Tsao, Melanie B Turner, Salim S Virani, Jenifer H Voeks, Joshua Z Willey, John T Wilkins, Jason Hy Wu, Heather M Alger, Sally S Wong, Paul Muntner. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 2017; 135: e146–e603.
[30] Martin J O'Donnell, Siu Lim Chin , Sumathy Rangarajan, Denis Xavier, Lisheng Liu, Hongye Zhang, Purnima Rao-Melacini, Xiaohe Zhang, Prem Pais, Steven Agapay, Patricio Lopez-Jaramillo, Albertino Damasceno, Peter Langhorne, Matthew J McQueen , Annika Rosengren, Mahshid Dehghan, Graeme J Hankey, Antonio L Dans , Ahmed Elsayed, Alvaro Avezum, Charles Mondo, Hans-Christoph Diener, Danuta Ryglewicz, Anna Czlonkowska, Nana Pogosova, Christian Weimar, Romaina Iqbal, Rafael Diaz , Khalid Yusoff , Afzalhussein Yusufali , Aytekin Oguz , Xingyu Wang , Ernesto Penaherrera, Fernando Lanas, Okechukwu S Ogah, Adesola Ogunniyi, Helle K Iversen, German Malaga, Zvonko Rumboldt, Shahram Oveisgharan, Fawaz Al Hussain, Daliwonga Magazi , Yongchai Nilanont , John Ferguson , Guillaume Pare, Salim Yusuf. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (interstroke): a case-control study. Lancet 2016; 388: 761–775.
[31] Chun Shing Kwok, Evangelos Kontopanteli , Phyo K Myint, Azfar Zaman , Colin Berry , Bernard Keavney, Jim Nolan , Peter F Ludman, Mark A de Belder , Iain Buchan, Mamas A Mamas. Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007–12[J]. European Heart Journal, 2015, 36, 1618–1628.
[32] Luke P Dawson, Justin A Cole, Terase F Lancefield, Andrew E Ajani, Nick Andrianopoulos , Amanda G Thrift, David J Clark, Angela L Brennan, Melanie Freeman , Jessica O'Brien, Martin Sebastian, William Chan, James A Shaw , Diem Dinh, Christopher M Reid, Stephen J Duffy. Lancefield Incidence and risk factors for stroke following percutaneous coronary intervention. International Journal of Stroke, 2020(0) 1–14.
[33]Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS, King SB, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty.Circulation. 1985; 72:1044–1052.
[34] Hoffman SJ, Routledge HC, Lennon RJ, Mustafa MZ, Rihal CS, Gersh BJ, Holmes DR, Gulati R. Procedural factors associated with percutaneous coronary intervention-related ischemic stroke.JACC Cardiovasc Interv. 2012; 5:200–206
[35] Eleni Rapsomaniki, Anoop Shah, Pablo Perel, Spiros Denaxas, Julie George, Owen Nicholas, Ruzan Udumyan, Gene Solomon Feder, Aroon D Hingorani, Adam Timmis, Liam Smeeth, Harry Hemingway. Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J 2014; 35:844–52.
[36] Robert W Yeh, Eric A Secemsky, Dean J Kereiakes, Sharon-Lise T Normand, Anthony H Gershlick, David J Cohen, John A Spertus , Philippe Gabriel Steg , Donald E Cutlip, Michael J Rinaldi, Edoardo Camenzin, William Wijns, Patricia K Apruzzese , Yang Song, Joseph M Massaro, Laura Mauri. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention.[J]. JAMA, 2016, 315(16):1735-1749.